ORGANON & CO
OGN · NYSE
Updated at 2026-10-14 08:31:37
- Today's High
- $13.79
- Today’s Low
- $13.76
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $13.80
- Previous Close
- $13.77
- Volume
- 932.35K
- Market Cap
- $3.61B
- P/E Ratio
- 17.30X
- EPS
- $0.78
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- 30 HUDSON STREET, JERSEY CITY, NJ, UNITED STATES, 07302
- Country
- US
- Listing Date
- 2021-05-14
- Fiscal Year End
- December
- Shares Outstanding
- 262.61M
- CIK
- 0001821825
- Website
- www.organon.com
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
Financial Metrics
Revenue
2026-06-30
$1.55B
2026-03-31
$1.46B
2025-12-31
$1.5B
2025-09-30
$1.6B
Operating Expenses
2026-06-30
$524M
2026-03-31
$517M
2025-12-31
$524M
2025-09-30
$499M
Net Income
2026-06-30
$108M
2026-03-31
$146M
2025-12-31
-$205M
2025-09-30
$160M
Net Profit Margin
2026-06-30
6.93%
2026-03-31
10%
2025-12-31
-13.6%
2025-09-30
9.98%
Earnings Per Share
2026-06-30
$0.80
2026-03-31
$0.71
2025-12-31
$0.63
2025-09-30
$1.01
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$371M
2026-03-31
$410M
2025-12-31
$69M
2025-09-30
$463M
Effective Tax Rate
2026-06-30
40.98%
2026-03-31
31.45%
2025-12-31
-38.51%
2025-09-30
34.15%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.55B | $1.46B | $1.5B | $1.6B |
| Operating Expenses | $524M | $517M | $524M | $499M |
| Net Income | $108M | $146M | -$205M | $160M |
| Net Profit Margin | 6.93% | 10% | -13.6% | 9.98% |
| Earnings Per Share | $0.80 | $0.71 | $0.63 | $1.01 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $371M | $410M | $69M | $463M |
| Effective Tax Rate | 40.98% | 31.45% | -38.51% | 34.15% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.